HELP — CYBIN INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1833141 ·
Last close
$12.59
Market Cap
$919.83M
52W High
$15.15
52W Low
$3.76
ADV30
1,724,032
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -49,082,000 | -47,819,000 | 259,655,000 | — | 17,568,000 |
| Mar 2026 | 0 | — | -47,859,000 | -46,995,000 | 251,166,000 | 157,258,000 | 19,377,000 |
| Dec 2025 | 0 | — | -41,210,000 | -42,668,000 | 290,112,000 | 195,128,000 | 16,178,000 |
| Sep 2025 | 0 | — | -28,894,000 | -33,722,000 | 181,246,000 | 83,752,000 | 42,250,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-133,271,000
Investing CF
$-1,363,000
Financing CF
$198,239,000
CapEx
$-1,373,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.87
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-389,535,000
Inventory
—
Receivables
$5,028,000
ST Investments
—
EBIT TTM
$-142,587,000
Pretax Income TTM
$-147,998,000
Interest Exp TTM
—
Analysts
9
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | -142,587,000 | -147,998,000 | 251,166,000 | 19,377,000 | 231,789,000 | -133,271,000 |
| Mar 2025 | 0 | -103,125,000 | -81,607,000 | 179,897,000 | 14,900,000 | 164,997,000 | -72,328,000 |
| Mar 2024 | 0 | -78,836,000 | -78,080,000 | 302,023,000 | 10,096,000 | 291,927,000 | -68,908,000 |
| Mar 2023 | 0 | -51,518,000 | -47,490,000 | 53,897,000 | 5,663,000 | 48,234,000 | -47,431,000 |
| Mar 2022 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.83
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $12.50 · spot: $12.59 · call volume: 132 · put volume: 50
Expected Move to 2026-10-16:
±$2.25
(17.87%) —
implied range
$10.34 –
$14.84
· ATM straddle on $12.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RIGL | RIGEL PHARMACEUTICALS INC | $922.04M | $49.36 | — |
| ALMS | ALUMIS INC. | $926.76M | $7.16 | — |
| JBIO | Jade Biosciences, Inc. | $912.62M | $14.35 | — |
| ANL | Adlai Nortye Group Ltd. | $904.51M | $15.40 | — |
| FBIOP | Fortress Biotech, Inc. | $936.35M | $16.52 | — |
News headlines (Yahoo Finance, 1h cache)
Helus Pharma Eyes Q4 Phase III Data for HLP-003 in Major Depression
2026-09-24 10:02 · Yahoo
Cybin Shareholders Weigh Helus Pharma Rebrand, Eight-Member Board
2026-09-22 13:02 · Yahoo
Cybin Eyes Q4 Phase 3 Data for Depression Drug HLP003
2026-09-21 05:02 · Yahoo
Cybin Eyes Q4 Phase III Depression Readout as Psychedelic Pipeline Advances
2026-09-21 00:01 · Yahoo
Cybin (HELP) Stock May Be Trading At A Premium Despite Fresh Depression Trial Data
2026-09-25 01:14 · Yahoo
Cybin (HELP) Shares Moved, What Is Behind The Fresh Attention?
2026-09-24 14:16 · Yahoo
Helus Pharma Announces Results of Annual and Special Meeting of Shareholders and Effective Date for Legal Name Change
2026-09-22 21:00 · Yahoo
Helus Pharma to Participate at the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit
2026-09-21 21:15 · Yahoo
Helus Pharma Presents New Analyses on HLP003 in Major Depressive Disorder at Psych Congress 2026
2026-09-21 11:30 · Yahoo
Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York
2026-09-10 11:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.